Interesting facts
Interesting Facts about 4-(8-methyl-8,9-dihydro-7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline
This intriguing compound, known as 4-(8-methyl-8,9-dihydro-7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline, is a part of the benzodiazepine class, which plays a significant role in medicinal chemistry.
Key Highlights:
- Pharmacological Importance: Compounds in the benzodiazepine family are well-known for their anxiolytic (anxiety-reducing) properties, making them critical in treating various mental health disorders such as anxiety and insomnia.
- Structural Complexity: This compound features a unique bicyclic core structure that consists of a benzodiazepine and a dioxole ring, providing it with distinctive chemical characteristics.
- Synthetic Pathways: The synthesis of such complex compounds presents an exciting challenge for chemists, often leading to the development of innovative synthetic methodologies and novel reactions.
- Research Potential: Due to its structural intricacies, this compound is a potential candidate for further research, especially in the field of pharmacology, where modifications could enhance its therapeutic efficacy and reduce side effects.
As a scientist or chemistry student, exploring such compounds not only expands your understanding of organic chemistry but also connects you with broader implications in drug development and therapeutic applications. The relationship between structure and biological activity remains a fascinating area of study that drives ongoing research in medicinal chemistry.
Synonyms
114460-08-1
GYKI 52895
4-(8-Methyl-8,9-dihydro-7H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d][1,2]diazepin-5-yl)aniline
GYKI-52895
H7KSE29GCH
1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine
4-(8-methyl-8,9-dihydro-7h-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline
4-(8,9-Dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine
CHEBI:79613
GYKI52895
Benzenamine, 4-(8,9-dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)-
7H-1,3-Dioxolo[4,5-h][2,3]benzodiazepine, benzenamine deriv.
1-(4-AMINOPHENYL)-4-METHYL-7,8-METHYLENEDIOXY-3.4-DIHYDRO-5H-2,3-BENZODIAZEPINE
869360-93-0
4-(8,9-Dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine
Benzenamine, 4-(8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-
AQTITSBNGSVQNZ-UHFFFAOYSA-N
UNII-H7KSE29GCH
Lopac0_000562
SCHEMBL6995439
CHEMBL1256984
DTXSID80921385
1-(4-Aminophenyl)-4-methyl-7,8-
CCG-204652
NCGC00015464-02
NCGC00015464-03
NCGC00093947-01
NCGC00093947-02
EU-0100562
G-120
SR-01000075406
Q5515085
SR-01000075406-1
methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine hydrochloride
1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3benzodiazepine
4-(8-Methyl-8,9-dihydro-2H,7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline
Solubility of 4-(8-methyl-8,9-dihydro-7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline
The solubility of 4-(8-methyl-8,9-dihydro-7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline (C17H17N3O2) can be influenced by several factors, including its chemical structure and the environment in which it is placed. Here are some key points regarding its solubility:
In conclusion, while the exact solubility data may require empirical testing, the structural features of C17H17N3O2 suggest that it may exhibit varied solubility characteristics depending on the solvent and environmental conditions. Its interaction with both polar and non-polar solvents makes it an interesting subject for further study.